Enox Biopharma Inc 4 SEC Filings

Filed On	Filing
03 Jan 2011	Form 4: Rewcastle John Cameron, Chief Executive Officer Acquired 1,327,292 Employee Option (Open Market Purchase)
05 Nov 2010	Form 4: David Itamar, Chief Financial Officer Disposed of 201,122 shares (Open Market Purchase) ($60.3K)
18 Aug 2010	Form 4: David Itamar, Chief Financial Officer Bought 201,122 shares ($60.3K) · Bought 25,000 shares ($50K) · Acquired 12,500 Warrant (Open Market Purchase)
18 Aug 2010	Form 4: Avniel Amir, Director Bought 25,000 shares ($50K) · Acquired 12,500 Warrant (Open Market Purchase)
24 Jun 2010	Form 4: David Itamar, Chief Financial Officer Granted 1,000,000 Option (right to buy)
22 Jun 2010	Form 4: Av-Gay Yossef, Director Granted 800,000 Option (right to buy)
22 Jun 2010	Form 4: Avniel Amir, Director Granted 1,886,938 Option (right to buy)
04 Nov 2009	Form 4: Av-Gay Yossef, Director Bought 80,846 shares ($10K)

Comments